Hyperfine HYPR
NASDAQ HYPR
$0.71 -0.01 (-1.77%)
At close: Nov 9, 2026 · 4:00 PM EST

Hyperfine (HYPR) Gains from Sales and Divestitures (2023 - 2026)

Updated

Analysis

Hyperfine (HYPR) Gains from Sales and Divestitures (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn
10 Hyperfine 72.35 Mn -68.53 Mn 1.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,000.00
Mar 31, 2026 -5,000.00
Sep 30, 2025 -120,000.00
Sep 30, 2024 -56,000.00
Sep 30, 2023 52,000.00
API Access

Hyperfine Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=HYPR&period=max&api_key=YOUR_API_KEY